Results from the phase-Ib/II combination trial MPNSG-0212: Ruxolitinib plus pomalidomide in myelofibrosis with anemia
ONCOLOGY RESEARCH AND TREATMENT(2021)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined